Greg Leonberger, FSA, EA, MAAA, FCA
Director of Research, Managing Partner
Last week was a painful one for the equity markets as fears about the coronavirus drove investors out of stocks and markets into correction territory. The following newsletter summarizes last week’s developments and provides specific commentary on what to watch for across the major asset classes that constitute investor portfolios.
Read > March 2: Coronavirus Update and Portfolio Guidance
As always, please reach out to your consultant or our research team for more details about any of the information presented in this update. For more Marquette coverage on coronavirus, reference our previous newsletter (January 28) and Chart of the Week posts (February 13, February 21, February 26).
The opinions expressed herein are those of Marquette Associates, Inc. (“Marquette”), and are subject to change without notice. This material is not financial advice or an offer to purchase or sell any product. Marquette reserves the right to modify its current investment strategies and techniques based on changing market dynamics or client needs.
04.26.2024
This video is a recording of a live webinar held April 25 by Marquette’s research team analyzing the…
04.25.2024
Any ride on the London Tube reminds riders to mind the gap: Beware the space between train car and platform…
04.24.2024
Foreign investment isn’t the only thing streaming into Japan. In 2023, the number of travelers to the country surpassed long-term…
04.16.2024
First quarter earnings season is getting started, with the largest banks reporting first. In the wake of last year’s regional…
04.11.2024
Based on implied probabilities derived from options markets, investors are currently forecasting an 82% chance that the European Central Bank…
04.01.2024
Chocolate eggs and bunnies may have appeared more expensive to shoppers this Easter weekend, as the price of cocoa futures…
Research alerts keep you updated on our latest research publications. Simply enter your contact information, choose the research alerts you would like to receive and click Subscribe. Alerts will be sent as research is published.
We respect your privacy. We will never share or sell your information.
If you have questions or need further information, please contact us directly and we will respond to your inquiry within 24 hours.
Contact Us >